Vancomycin (as HCl) 500mg/vial, 1g/vial; lyophilized pwd for IV infusion after reconstitution and dilution. Not for prophylaxis of endophthalmitis. Renal insufficiency. Monitor hearing, blood, renal ...
Guidelines recommend against use of midline catheters for vancomycin-based outpatient parenteral antimicrobial therapy (OPAT), but evidence supporting the guidance is limited. This retrospective study ...
Ready-to-infuse sepsis therapy marks new advancement in time-critical treatment LONDON, July 2, 2025 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today ...
In late 2021, the Rome Proposal for diagnosing acute exacerbations of chronic obstructive pulmonary disease (AECOPD) and grading their severity was published. The 2023 Global Strategy for the ...
Four medicines received positive opinions from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) last week, expanding treatment options for cancer, rare ...
Please provide your email address to receive an email when new articles are posted on . Results showed use of IV vancomycin was linked with a higher periprosthetic joint infection risk vs. use of ...
Clinicians should treat ventilator‑associated pneumonia (VAP) until the infection is controlled and the patient is clearly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results